The Smad pathway in transforming growth factor-beta signaling. 2003

Haiyan Lin, and Hongmei Wang, and Cheng Zhu
Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

The Smad pathway is involved in transforming growth factor-beta (TGF-beta) signal transduction. The Smad complex binds with the promoter of target gene to modulate gene transcription. Various transcriptional coactivators and corepressors associate directly with Smads for appropriate binding of Smads to target promoters and regulation of Smads transcriptional activities. The ultimate degradation of Smads mediated by the ubiquitin-proteasome pathway (UPP) has been established as a mechanism to shut off the Smad pathway. In addition to the Smad pathway, TGF-beta can also activate other signaling pathway such as the MAPK pathway. The cross-talk of the Smad pathway with other signaling pathways constitutes an important mechanism for the regulatory network of TGF-beta signaling.

UI MeSH Term Description Entries

Related Publications

Haiyan Lin, and Hongmei Wang, and Cheng Zhu
September 2000, Kidney international. Supplement,
Haiyan Lin, and Hongmei Wang, and Cheng Zhu
October 2006, Cancer letters,
Haiyan Lin, and Hongmei Wang, and Cheng Zhu
March 2003, Cancer research,
Haiyan Lin, and Hongmei Wang, and Cheng Zhu
June 2007, The Journal of biological chemistry,
Haiyan Lin, and Hongmei Wang, and Cheng Zhu
January 2000, Breast cancer research : BCR,
Haiyan Lin, and Hongmei Wang, and Cheng Zhu
November 2004, Journal of cardiovascular pharmacology,
Haiyan Lin, and Hongmei Wang, and Cheng Zhu
December 2003, The Journal of investigative dermatology,
Haiyan Lin, and Hongmei Wang, and Cheng Zhu
October 1999, Kidney international,
Haiyan Lin, and Hongmei Wang, and Cheng Zhu
January 2002, The Journal of biological chemistry,
Copied contents to your clipboard!